Google search on Leronlimab + glioblastoma+Albert Einstein College of Medicine and Montefiore Medical Center shows only this Jay's announcement of February 2024:

I

Quote:

---

n addition, the Company announced that its research partnership with Albert Einstein College of Medicine and Montefiore Medical Center is moving forward with a pre-clinical trial designed to study leronlimab in glioblastoma, a common and often untreatable form of primary brain cancer. Initial preparations have commenced for a trial to take place in 2024, one of potentially several pre-clinical trials to be conducted with Montefiore Medical Center.

As to the partnership with Montefiore Medical Center, Dr. Lalezari stated, “I am excited to start this pre-clinical trial with Albert Einstein College of Medicine and Montefiore Medical Center in New York. Glioblastoma is a common and often untreatable form of primary brain cancer. CytoDyn is fortunate to be able to evaluate the potential effects of leronlimab in a pre-clinical model of this all too often deadly cancer.”

---

I wasn't able to find any mention of this trial either commenced or planned by searching the websites of these organizations. I wish the company confirms that the trial did actually take place.